Nektar Therapeutics (NKTR): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2025-08-08. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

20.38M
As of 2025-12-31
20.38M
As of 2026-06-30
191.38M2010-12-31: 94.52M2011-12-31: 114.48M2012-12-31: 115.26M2013-12-31: 116.49M2014-12-31: 131.22M2015-12-31: 135.29M2016-12-31: 153.21M2017-12-31: 159.52M2018-12-31: 173.53M2019-12-31: 176.50M2020-12-31: 180.09M2021-12-31: 185.47M2022-12-31: 188.56M2023-12-31: 191.38M2024-12-31: 12.39M2025-12-31: 20.38M20.38M
2010-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3120.38M+64.5%2026-03-13, Balance as of period end
2024-12-3112.39Mn/c2026-03-13, Balance as of period end
2023-12-31191.38M+1.5%2025-03-14, Balance as of period end
2022-12-31188.56M+1.7%2024-03-05, Balance as of period end
2021-12-31185.47M+3.0%2023-02-28, Balance as of period end
2020-12-31180.09M+2.0%2022-03-01, Balance as of period end
2019-12-31176.50M+1.7%2021-02-26, Balance as of period end
2018-12-31173.53M+8.8%2020-02-28, Balance as of period end
2017-12-31159.52M+4.1%2019-03-01, Balance as of period end
2016-12-31153.21M+13.2%2018-03-01, Balance as of period end
2015-12-31135.29M+3.1%2017-03-01, Balance as of period end
2014-12-31131.22M+12.6%2016-02-29, Balance as of period end
2013-12-31116.49M+1.1%2015-02-26, Balance as of period end
2012-12-31115.26M+0.7%2014-02-27, Balance as of period end
2011-12-31114.48M+21.1%2013-03-01, Balance as of period end
2010-12-3194.52Mn/a2012-02-29, Balance as of period end